血管性痴呆患者认知功能障碍采用舒血宁与吡拉西坦治疗对其MMSE及ADL评分的影响  

Effect of Shuxuening and piracetam on cognitive impairment in patients with vascular dementia and its influence on MMSE and ADL score

作　　者：庞啸虎[1] 吴秀玮 许庆[1] 高丽[1] PANG Xiao-hu;WU Xiu-wei;XU Qing;Gao Li(Neurology Department,the First People's Hospital of Xuzhou,Xuzhou 221002,China)

机构地区：[1]徐州市第一人民医院神经内科,江苏徐州221002

出　　处：《临床医学研究与实践》2017年第35期32-33,共2页Clinical Research and Practice

摘　　要：目的探讨血管性痴呆患者认知功能障碍采用舒血宁与吡拉西坦治疗对其MMSE及ADL评分的影响。方法将2016年2月至2017年2月在我院精神病科治疗的104例血管性痴呆伴有认知功能障碍患者随机分为对照组和观察组,各52例。对照组患者单用吡拉西坦治疗,观察组采用舒血宁联合吡拉西坦治疗。对比分析两组患者的临床疗效、治疗前、后的症状变化及生活能力改善情况。结果观察组患者的治疗总有效率为94.23%,明显高于对照组的75.00%(P<0.05)。治疗后,两组患者定向力、回忆能力、语言能力、MMSE总分评分均升高,且观察组均明显高于对照组(P<0.05)。治疗后,两组患者的躯体生活自理能力、使用工具能力及ADL总分评分均明显降低,且观察组明显低于对照组(P<0.05)。结论血管性痴呆患者认知功能障碍采用舒血宁与吡拉西坦治疗效果显著,能明显改变痴呆及认知功能障碍的症状,延缓患者的脑部功能衰退,改进日常生活的能力。Objective To study the effect of Shuxuening and piracetam on cognitive impairment in patients with vascular dementia and its influence on MMSE and ADL scores.Methods From February 2016 to February 2017,104 cases of vascular dementia patients with cognitive impairment in our hospital were randomly divided into control group and observation group,with 52 cases in each group.Patients in the control group were treated with piracetam alone,while patients in the observation group received Shuxuening combined with piracetam.The clinical efficacy,changes of symptoms,improvement of living ability before and after treatment were compared between the two groups.Results The total effective rate of the observation group was 94.23%,which was significantly higher than 75.00%of the control group(P<0.05).After treatment,the scores of orientation ability,recall ability,language ability and total MMSE score of the two groups increased,and those of the observation group were higher than the control group(P<0.05).After treatment,the scores of physical activity self-care ability,using tools and total ADL score of the two groups decreased,and those of the observation group were lower than the control group(P<0.05).Conclusion In the treatment of cognitive dysfunction in patients with vascular dementia,Shuxuening combined with Piracetam can effectively improve the symptoms of dementia and cognitive dysfunction,delay the decline of brain function,and promote the improvement of daily living ability.

关 键 词：血管性痴呆 认知功能障碍 舒血宁 吡拉西坦 

分 类 号：R749.1[医药卫生—神经病学与精神病学]